Sameh Abdelmalak, Director, Oncology, Educational Partnerships at VuMedi, made the following post on X:
“Check out Check out Dr. Giuseppe Curigliano, discussing ASCO24 ‘DESTINY-Breast06 – T-DXd vs. Physician’s Choice of Chemotherapy in HR+/HER2-Low/Ultralow mBC After Endocrine Therapy’.
Full video on VuMedi.”
Video attached to the post.
Source: Sameh Abdelmalak/X